Healthcare provider profile · identity verified

Tommy D Le, D.O.

Family Practice · CARLSBAD, CA · NPI 1821090788

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	209
Rosuvastatin Calcium	Rosuvastatin Calcium	247	95
Lisinopril	Lisinopril	235	85
Amlodipine Besylate	Amlodipine Besylate	206	79
Levothyroxine Sodium	Levothyroxine Sodium	201	73
Losartan Potassium	Losartan Potassium	184	68
Gabapentin	Gabapentin	169	70
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	159	66
Metformin Hcl	Metformin Hcl	155	63
Tamsulosin Hcl	Tamsulosin Hcl	142	49
Omeprazole	Omeprazole	140	55
Trazodone Hcl	Trazodone Hcl	122	53
Mupirocin	Mupirocin	115	76
Wixela Inhub	Fluticasone Propion/Salmeterol	112	66
Atenolol	Atenolol	108	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	34
Prednisone	Prednisone	101	83
Hydrochlorothiazide	Hydrochlorothiazide	94	37
Albuterol Sulfate Hfa	Albuterol Sulfate	92	78
Allopurinol	Allopurinol	92	30
Alendronate Sodium	Alendronate Sodium	76	28
Amoxicillin	Amoxicillin	66	50
Triamcinolone Acetonide	Triamcinolone Acetonide	66	35
Potassium Chloride	Potassium Chloride	60	22
Metoprolol Tartrate	Metoprolol Tartrate	58	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	15
Sertraline Hcl	Sertraline Hcl	56	23
Simvastatin	Simvastatin	56	29
Tramadol Hcl	Tramadol Hcl	51	27
Ezetimibe	Ezetimibe	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	16
Pantoprazole Sodium	Pantoprazole Sodium	50	20
Glipizide	Glipizide	49	18
Metformin Hcl Er	Metformin Hcl	49	19
Terazosin Hcl	Terazosin Hcl	48	21
Jardiance	Empagliflozin	45	12
Meloxicam	Meloxicam	44	18
Cephalexin	Cephalexin	43	36
Pradaxa	Dabigatran Etexilate Mesylate	39	16
Ozempic	Semaglutide	38	suppressed
Acyclovir	Acyclovir	34	22
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Finasteride	Finasteride	32	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Humulin N	Insulin Nph Human Isophane	28	suppressed
Hydrocortisone	Hydrocortisone	28	15
Cefadroxil	Cefadroxil	27	25
Mirtazapine	Mirtazapine	27	14
Ciclopirox	Ciclopirox	26	16
Ondansetron Odt	Ondansetron	26	13
Propranolol Hcl	Propranolol Hcl	26	17
Colchicine	Colchicine	25	12
Fenofibrate	Fenofibrate	24	suppressed
Metoprolol Succinate	Metoprolol Succinate	24	13
Famotidine	Famotidine	23	suppressed
Azithromycin	Azithromycin	22	21
Spironolactone	Spironolactone	22	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Estradiol	Estradiol	20	14
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Glipizide Er	Glipizide	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Alvesco	Ciclesonide	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Furosemide	Furosemide	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	12
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Eliquis	Apixaban	13	suppressed
Temazepam	Temazepam	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Ofloxacin	Ofloxacin	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error